HITIQ Targets 120,000 PROTEQT Mouthguards by 2026 in Global Deal

A Landmark Partnership in Athlete Safety

HITIQ Limited, an innovator in concussion management technology, has announced a groundbreaking exclusive global agreement with Shock Doctor, the world’s leading mouthguard brand. This collaboration brings together HITIQ’s cutting-edge PROTEQT sensor technology with Shock Doctor’s expertise in mouthguard design, creating a self-fit “boil and bite” instrumented mouthguard that promises to redefine athlete safety standards worldwide.

The PROTEQT mouthguard is not just another protective gear; it integrates advanced impact sensors that detect head impacts and assess concussion risks in real time. This technology is backed by validation from elite sporting bodies such as the AFL and NRL, and it is now poised to extend its reach into community sports through partnerships with organizations like VAFA, AFL Barwon, and Westfield Sports High.

Scaling Production and Market Reach

With Shock Doctor’s unparalleled global production capabilities, HITIQ plans to manufacture 20,000 PROTEQT units in 2025, scaling up to 100,000 units in 2026. This ambitious production schedule reflects confidence in the product’s market potential and the growing demand for reliable concussion management solutions across all levels of sport.

The co-branded mouthguard leverages Shock Doctor’s extensive distribution network, available in over 20,000 retail locations worldwide, ensuring that the PROTEQT system can be delivered efficiently and affordably to athletes everywhere. The partnership also benefits from regulatory endorsements, including World Rugby’s approval and a U.S. patent on HITIQ’s Nexus technology, further cementing its position as a global leader in concussion safety.

Funding Growth Through a Rights Issue

To support this rapid commercialisation, HITIQ has launched a non-renounceable rights issue aiming to raise approximately $2.92 million. Eligible shareholders can subscribe to new shares at 2.2 cents each, with options attached, providing the company with the necessary capital to scale production and expand market penetration. The rights issue timetable is set to close by 20 June 2025, with the company actively addressing shareholder queries to ensure smooth participation.

Executive Chair Earl Eddings described the agreement as a “defining moment” for HITIQ, highlighting the potential for PROTEQT to transform concussion management globally. Meanwhile, Shock Doctor’s SVP of Product Development, Jay Turkbas, praised the collaboration as a “groundbreaking mouthguard technology solution” that marries sensor innovation with proven mouthguard design excellence.

Looking Ahead

As PROTEQT moves from development to market-ready status, the partnership’s success will hinge on adoption rates within community sports and the broader athletic market. The combination of advanced technology, trusted branding, and strategic partnerships positions HITIQ well to capitalize on growing awareness around concussion risks and the demand for smarter protective equipment.